Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.0100
+0.1100
+(3.79%)
At close: March 5 at 4:00:02 PM EST
3.0000
-0.01
(-0.33%)
Pre-Market: 8:00:02 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-126,936
-85,395
-120,982
-87,005
296,734
Investing Cash Flow
87,246
40,303
-455,410
-4
-26
Financing Cash Flow
267
257
370
1,465
531,748
End Cash Position
98,463
143,823
188,658
764,680
850,224
Capital Expenditure
--
--
-1,943
-4
-26
Issuance of Capital Stock
--
--
230
1,465
531,748
Free Cash Flow
-126,936
-85,395
-122,925
-87,009
296,708
12/31/2020 - 10/30/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANTX AN2 Therapeutics, Inc.
1.2500
+8.70%
ACHL Achilles Therapeutics plc
1.3900
+1.46%
GLTO Galecto, Inc.
4.3300
+1.88%
ITOS iTeos Therapeutics, Inc.
7.26
+5.99%
PMVP PMV Pharmaceuticals, Inc.
1.3700
+6.20%
LVTX LAVA Therapeutics N.V.
1.3200
+3.13%
LSTA Lisata Therapeutics, Inc.
2.3700
+10.23%
SNPX Synaptogenix, Inc.
2.8373
+4.70%
IPSC Century Therapeutics, Inc.
0.6076
+0.41%
HLVX HilleVax, Inc.
1.8200
+2.25%